Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Sensus Healthcare (SRTS) over the last 10 years, with Q3 2025 value amounting to $9.3 million.

  • Sensus Healthcare's Receivables - Net fell 4495.61% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 4495.61%. This contributed to the annual value of $19.7 million for FY2024, which is 8535.46% up from last year.
  • As of Q3 2025, Sensus Healthcare's Receivables - Net stood at $9.3 million, which was down 4495.61% from $12.6 million recorded in Q2 2025.
  • Over the past 5 years, Sensus Healthcare's Receivables - Net peaked at $19.7 million during Q4 2024, and registered a low of $4.1 million during Q1 2021.
  • In the last 5 years, Sensus Healthcare's Receivables - Net had a median value of $10.6 million in 2023 and averaged $11.8 million.
  • Over the last 5 years, Sensus Healthcare's Receivables - Net had its largest YoY gain of 32153.89% in 2021, and its largest YoY loss of 4825.63% in 2021.
  • Sensus Healthcare's Receivables - Net (Quarter) stood at $12.1 million in 2021, then skyrocketed by 42.61% to $17.3 million in 2022, then crashed by 38.46% to $10.6 million in 2023, then soared by 85.35% to $19.7 million in 2024, then crashed by 52.68% to $9.3 million in 2025.
  • Its Receivables - Net was $9.3 million in Q3 2025, compared to $12.6 million in Q2 2025 and $18.0 million in Q1 2025.